Kimyrsa and Orbactiv – A Tale of Two Formulations

Kimyrsa is a new formulation (NF) of the original formulation of oritavancin ([OF] Orbactiv). Comparatively, the obvious benefit with this product is the shortened infusion time and flexibility with solution compatibility, but otherwise maintains a similar pharmacokinetic and microbiologic profile....

Descripción completa

Detalles Bibliográficos
Autores principales: Jackson, Brittany T, Cluck, David B, Henao-Martínez, Andrés F, Chastain, Daniel B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010140/
https://www.ncbi.nlm.nih.gov/pubmed/36923104
http://dx.doi.org/10.2147/DDDT.S324285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010140/
https://www.ncbi.nlm.nih.gov/pubmed/36923104
http://dx.doi.org/10.2147/DDDT.S324285

Ejemplares similares